TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT05931276: CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

Sponsor: VA Office of Research and Development · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 2540 pts

Competing Trials Overlap

12 Active Trials

Excess Burn Exposure

$15,086,080

Rescue Site Savings

+$9,947,384

Unlock Full NCT05931276 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05931276 Rescue Dossier →